INSM Insmed Inc

Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases.

$38.00  -0.45 (-1.17%)
As of 03/03/2021 15:59:32 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
USA
02/21/2001
103,043,347
762,629
$3,962,016,692
0.00%
SEC Edgar Online
10-Q
10-K
457669307
US4576693075
2614487

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-13.47
14.32
24.10
-106.60%
-178.87%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy